Cormac Sheridan

The EU must continue to support human embryonic stem cell research to maintain its lead in regenerative medicine. The upcoming Irish Presidency needs to recognise the importance of this research and resist calls for a ban on funding in Horizon 2020

The R&D budget is slashed, but there’s a silver lining to the economic crisis as the costs of innovation, entrepreneurship and building new companies are reduced.

Estonia is using Structural Funds, Framework grants and international collaboration to build its science base and drive innovation.

i2india this week oversees the opening of Technovate-India, an incubator it will run with its parent Imperial Innovations, the tech transfer arm of Imperial College London.

But the incoming Research and Innovation Commissioner Maire Geoghegan-Quinn can expect a grilling on her experience and some of her past associations.

Can new-look Academic Health Science Centres overcome institutional inertia to boost innovation in healthcare?

Spanning a national boundary, Medicon Valley’s issues with joint funding and differing tax regimes are a microcosm of the larger European problem. Part 4 of our series on clusters.

Ireland’s remarkable ability to attract inward investment has made it the economic role model for aspiring small countries. Now it plans to lure corporate R&D.

Alexander von Gabain and his team laid the foundations of an enterprise that would rise to the top of the continent’s biotechnology pile – and rewrite the region’s rules for biotechnology start-ups.

The Open Source software movement has broken the stranglehold of expensive, proprietary products. Could the same thing happen in biotechnology?